Nonapoptotic functions of FADD-binding death receptors and their signaling molecules

Current Opinion in Cell Biology

Volumn 17, Issue 6, 2005, Pages 610-616

  Park, Sun Mi ^a   Schickel, Robert ^a   Peter, Marcus E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CASPASE 8; DEATH RECEPTOR; DEATH RECEPTOR 3; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FLICE INHIBITORY PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; UROKINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; B LYMPHOCYTE; BREAST EPITHELIUM; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; HELA CELL; HUMAN; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASES; CELL CYCLE PROTEINS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 27544432516     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2005.09.010     Document Type: Review

References (72)

1. T. Hehlgans, and K. Pfeffer The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games Immunology 115 2005 1 20
2. H. Wajant, K. Pfizenmaier, and P. Scheurich Tumor necrosis factor signaling Cell Death Differ 10 2003 45 65
3. D. Wallach, E.E. Varfolomeev, N.L. Malinin, Y.V. Goltsev, A.V. Kovalenko, and M.P. Boldin Tumor necrosis factor receptor and Fas signaling mechanisms Annu Rev Immunol 17 1999 331 367
4. K. Schulze-Osthoff, D. Ferrari, M. Los, S. Wesselborg, and M.E. Peter Apoptosis signaling by death receptors Eur J Biochem 254 1998 439 459
5. M.E. Peter, and P.H. Krammer The CD95(APO-1/Fas) DISC and beyond Cell Death Differ 10 2003 26 35
6. B.C. Barnhart, E.C. Alappat, and M.E. Peter The CD95 type I/type II model Semin Immunol 15 2003 185 193
7. M.E. Peter, B.C. Barnhart, and A. Algeciras-Schimnich A.W. Thomson M.T. Lotze edn 4th The Cytokine Handbook: CD95L/FasL and its receptor CD95 APO-1/Fas) vol 2 2003 Academic Press London
8. M.E. Peter, A.E. Heufelder, and M.O. Hengartner Advances in apoptosis research Proc Natl Acad Sci USA 94 1997 12736 12737
9. J. Desbarats, and M.K. Newell Fas engagement accelerates liver regeneration after partial hepatectomy Nat Med 6 2000 920 923
10. J. Desbarats, R.B. Birge, M. Mimouni-Rongy, D.E. Weinstein, J.S. Palerme, and M.K. Newell Fas engagement induces neurite growth through ERK activation and p35 upregulation Nat Cell Biol 5 2003 118 125 Stimulation of CD95 induces neurite outgrowth in sensory neurons through activation of ERK. Injection of anti-CD95 antibodies accelerates functional recovery after sciatic nerve injury in mice.
11. E. Reichmann The biological role of the Fas/FasL system during tumor formation and progression Semin Cancer Biol 12 2002 309 315
12. R. Imamura, K. Konaka, N. Matsumoto, M. Hasegawa, M. Fukui, N. Mukaida, T. Kinoshita, and T. Suda Fas ligand induces cell-autonomous NF-κB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-α J Biol Chem 279 2004 46415 46423
13. C. Sekine, H. Yagita, T. Kobata, T. Hasunuma, K. Nishioka, and K. Okumura Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis Biochem Biophys Res Commun 228 1996 14 20
14. M.R. Alderson, R.J. Armitage, E. Maraskovsky, T.W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D.H. Lynch Fas transduces activation signals in normal human T lymphocytes J Exp Med 178 1993 2231 2235
15. R.A. Freiberg, D.M. Spencer, K.A. Choate, H.J. Duh, S.L. Schreiber, G.R. Crabtree, and P.A. Khavari Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts J Invest Dermatol 108 1997 215 219
16. B.B. Aggarwal, S. Singh, R. LaPushin, and K. Totpal Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor FEBS Lett 364 1995 5 8
17. L.B. Owen-Schaub, S. Meterissian, and R.J. Ford Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin J Immunother 14 1993 234 241
18. H. Shinohara, H. Yagita, Y. Ikawa, and N. Oyaizu Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation Cancer Res 60 2000 1766 1772
19. M. Borset, H. Hjorth-Hansen, A.C. Johnsen, C. Seidel, A. Waage, T. Espevik, and A. Sundan Apoptosis, proliferation and NF-κB activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor Eur J Haematol 63 1999 345 353
20. S. Fulda, and K.M. Debatin Signaling through death receptors in cancer therapy Curr Opin Pharmacol 4 2004 327 332
21. S. Nagata Steering anti-cancer drugs away from the TRAIL Nat Med 6 2000 502 503
22. B.C. Barnhart, P. Legembre, E. Pietras, C. Bubici, G. Franzoso, and M.E. Peter CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells EMBO J 23 2004 3175 3185 Stimulation of CD95 in a large number of CD95-apoptosis-resistant human tumor cell lines results in increased in vitro motility and invasiveness. CD95 stimulation causes activation of multiple non-apoptotic signaling pathways, including a pathway in which activated NF-κB causes upregulation of urokinase plasminogen activator, which contributes to the motility and invasiveness response.
23. J.K. Lee, T.J. Sayers, T.C. Back, J.M. Wigginton, and R.H. Wiltrout Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer Apoptosis 8 2003 151 160 Overexpression of CD95 in the CD95-apoptosis-resistant mouse Lewis lung carcinoma cell line 3LL renders the cells sensitive to CD95-mediated apoptosis in vitro. However, in vivo cells expressing CD95 grow faster as solid tumors when compared to control transfectants. In certain tumor cells CD95 can act as tumor promotor. Stimulation by endogenous CD95 ligand and the presence of a functional intracellular domain in CD95 are required for its tumor promoting activity.
24. A. Trauzold, C. Roder, B. Sipos, K. Karsten, A. Arlt, P. Jiang, J.I. Martin-Subero, D. Siegmund, S. Muerkoster, and L. Pagerols-Raluy CD95 and TRAF2 promote invasiveness of pancreatic cancer cells FASEB J 19 2005 620 622
25. P. Legembre, R. Schickel, B.C. Barnhart, and M.E. Peter Identification of SNF1/AMP kinase-related kinase as an NF-κB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness J Biol Chem 279 2004 46742 46747
26. K. Seino, N. Kayagaki, K. Okumura, and H. Yagita Antitumor effect of locally produced CD95 ligand Nat Med 3 1997 165 170
27. S.M. Kang, D.B. Schneider, Z. Lin, D. Hanahan, D.A. Dichek, P.G. Stock, and S. Baekkeskov Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction Nat Med 3 1997 738 743
28. K. Miwa, M. Asano, R. Horai, Y. Iwakura, S. Nagata, and T. Suda Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand Nat Med 4 1998 1287 1292
29. D.R. Park, A.R. Thomsen, C.W. Frevert, U. Pham, S.J. Skerrett, P.A. Kiener, and W.C. Liles Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages J Immunol 170 2003 6209 6216
30. J.H. Ahn, S.M. Park, H.S. Cho, M.S. Lee, J.B. Yoon, J. Vilcek, and T.H. Lee Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-κB-dependent gene expression J Biol Chem 276 2001 47100 47106
31. N. Hagimoto, K. Kuwano, M. Kawasaki, M. Yoshimi, Y. Kaneko, R. Kunitake, T. Maeyama, T. Tanaka, and N. Hara Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation Am J Respir Cell Mol Biol 21 1999 436 445
32. A. Almasan, and A. Ashkenazi Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy Cytokine Growth Factor Rev 14 2003 337 348
33. M.E. Peter Taming TRAIL: the winding path to a novel form of cancer therapy Cell Death Differ 12 2005 693 694
34. M. Leverkus, M.R. Sprick, T. Wachter, A. Denk, E.B. Brocker, H. Walczak, and M. Neumann TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2 J Invest Dermatol 121 2003 149 155
35. P. Secchiero, A. Gonelli, E. Carnevale, D. Milani, A. Pandolfi, D. Zella, and G. Zauli TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways Circulation 107 2003 2250 2256
36. J. Morel, R. Audo, M. Hahne, and B. Combe Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt J Biol Chem 280 2005 15709 15718
37. S. Kreuz, D. Siegmund, J.J. Rumpf, D. Samel, M. Leverkus, O. Janssen, G. Hacker, O. Dittrich-Breiholz, M. Kracht, and P. Scheurich NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP J Cell Biol 166 2004 369 380
38. P.M. Chaudhary, M. Eby, A. Jasmin, A. Bookwalter, J. Murray, and L. Hood Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway Immunity 7 1997 821 830
39. B.C. Barnhart, E.M. Pietras, A. Algeciras-Schimnich, L. Salmena, K. Sayama, A. Hakem, and M.E. Peter Overcoming CD95 apoptosis resistance in certain cells through noncanonical activation of caspase-8 Cell Death Differ 12 2004 25 37
40. P. Legembre, B.C. Barnhart, L. Zheng, S. Vijayan, S.E. Straus, J. Puck, J.K. Dale, M. Lenardo, and M.E. Peter Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds EMBO Rep 5 2004 1084 1089 The CD95 death domain is essential for CD95 to induce apoptosis. By contrast, activation of non-apoptotic pathways through CD95, such as the activation of MAP kinases and NF-κB, only requires one functional CD95 allele, as found in human ALPS type Ia patients. Only when both CD95 alleles are mutated can neither apoptotic nor nonapoptotic pathways be engaged by CD95 in mouse splenocytes.
41. T. Kataoka, R.C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, and M. Kovacsovics The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways Curr Biol 10 2000 640 648
42. P. Legembre, B.C. Barnhart, and M.E. Peter The relevance of NF-κB for CD95 signaling in tumor cells Cell Cycle 3 2004 1235 1239
43. M. Mandal, S.B. Maggirwar, N. Sharma, S.H. Kaufmann, S.C. Sun, and R. Kumar Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-κB signaling pathway J Biol Chem 271 1996 30354 30359
44. J.O. Pyo, M.H. Jang, Y.K. Kwon, H.J. Lee, J.I. Jun, H.N. Woo, D.H. Cho, B. Choi, H. Lee, and J.H. Kim Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death J Biol Chem 280 2005 20722 20729
45. Y. Ma, H. Liu, H. Tu-Rapp, H.J. Thiesen, S.M. Ibrahim, S.M. Cole, and R.M. Pope Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation Nat Immunol 5 2004 380 387
46. S. Balachandran, E. Thomas, and G.N. Barber A FADD-dependent innate immune mechanism in mammalian cells Nature 432 2004 401 405 FADD is important in host defense. Mammalian cells lacking FADD expression are hypersensitive to viral infection as they fail to respond to dsRNA with expression of genes such as Type I interferons. A novel signaling pathway links FADD through RIP with Tak-1 and IRF-3.
47. J. Zhang, N.H. Kabra, D. Cado, C. Kang, and A. Winoto FADD-deficient T cells exhibit a disaccord in regulation of the cell cycle machinery J Biol Chem 276 2001 29815 29818
48. J. Zhang, D. Cado, A. Chen, N.H. Kabra, and A. Winoto Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 Nature 392 1998 296 300
49. K. Newton, A.W. Harris, M.L. Bath, K.G. Smith, and A. Strasser A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes EMBO J 17 1998 706 718
50. C.M. Walsh, B.G. Wen, A.M. Chinnaiyan, K. O'Rourke, V.M. Dixit, and S.M. Hedrick A role for FADD in T cell activation and development Immunity 8 1998 439 449
51. M. Zornig, A.O. Hueber, and G. Evan p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice Curr Biol 8 1998 467 470
52. A.O. Hueber, M. Zornig, A.M. Bernard, M. Chautan, and G. Evan A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts J Biol Chem 275 2000 10453 10462
53. E.C. Alappat, J. Volkland, and M.E. Peter Cell cycle effects by C-FADD depend on its C-terminal phosphorylation site J Biol Chem 278 2003 41585 41588
54. Z.C. Hua, S.J. Sohn, C. Kang, D. Cado, and A. Winoto A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region Immunity 18 2003 513 521 T cells from FADD knockout mice reconstituted with FADD with a S191D replacement are defective in proliferation and cell cycle progression in a similar manner to T cells from mice lacking FADD expression completely, establishing the relevance of the Ser191 phosphorylation site in FADD in vivo.
55. 2/M regulator. Phosphorylated FADD colocalizes with CKIα on mitotic spindles early during mitosis, and blocking the activity of CKIα eliminates the spindle check point.
56. Y. Shikama, M. Yamada, and T. Miyashita Caspase-8 and caspase-10 activate NF-κB through RIP, NIK and IKKα kinases Eur J Immunol 33 2003 1998 2006
57. K. Shimada, M. Nakamura, E. Ishida, M. Kishi, S. Yonehara, and N. Konishi Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cells Jpn J Cancer Res 93 2002 1164 1174
58. L. Salmena, B. Lemmers, A. Hakem, E. Matysiak-Zablocki, K. Murakami, P.Y. Au, D.M. Berry, L. Tamblyn, A. Shehabeldin, and E. Migon Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity Genes Dev 17 2003 883 895 Tissue-specific knock-out of caspase-8 reveals a role for caspase-8 in the activation and differentiation of peripheral T cells. Caspase-8-deficient mice are defective in mounting an immune response in response to viral infection.
59. T.B. Kang, T. Ben-Moshe, E.E. Varfolomeev, Y. Pewzner-Jung, N. Yogev, A. Jurewicz, A. Waisman, O. Brenner, R. Haffner, and E. Gustafsson Caspase-8 serves both apoptotic and nonapoptotic roles J Immunol 173 2004 2976 2984
60. H.J. Chun, L. Zheng, M. Ahmad, J. Wang, C.K. Speirs, R.M. Siegel, J.K. Dale, J. Puck, J. Davis, and C.G. Hall Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency Nature 419 2002 395 399
61. H. Su, N. Bidere, L. Zheng, A. Cubre, K. Sakai, J. Dale, L. Salmena, R. Hakem, S. Straus, and M. Lenardo Requirement for caspase-8 in NF-κB activation by antigen receptor Science 307 2005 1465 1468
62. M. Thome, and J. Tschopp Regulation of lymphocyte proliferation and death by FLIP Nat Rev Immunol 1 2001 50 58
63. A. Dohrman, J.Q. Russell, S. Cuenin, K. Fortner, J. Tschopp, and R.C. Budd Cellular FLIP long form augments caspase activity and death of T cells through heterodimerization with and activation of caspase-8 J Immunol 175 2005 311 318
64. O. Micheau, M. Thome, P. Schneider, N. Holler, J. Tschopp, D.W. Nicholson, C. Briand, and M.G. Grutter The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex J Biol Chem 277 2002 45162 45171
65. D.W. Chang, Z. Xing, Y. Pan, A. Algeciras-Schimnich, B.C. Barnhart, S. Yaish-Ohad, M.E. Peter, and X. Yang c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis EMBO J 21 2002 3704 3714
66. T. Wachter, M. Sprick, D. Hausmann, A. Kerstan, K. McPherson, G. Stassi, E.B. Brocker, H. Walczak, and M. Leverkus cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-κB activation at the death-inducing signaling complex in human keratinocytes J Biol Chem 279 2004 52824 52834
67. W.C. Yeh, J.L. Pompa, M.E. McCurrach, H.B. Shu, A.J. Elia, A. Shahinian, M. Ng, A. Wakeham, W. Khoo, and K. Mitchell FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis Science 279 1998 1954 1958
68. W.C. Yeh, A. Itie, A.J. Elia, M. Ng, H.B. Shu, A. Wakeham, C. Mirtsos, N. Suzuki, M. Bonnard, and D.V. Goeddel Requirement for Casper (c-FLIP) in regulation of death-receptor-induced apoptosis and embryonic development Immunity 12 2000 633 642
69. E.E. Varfolomeev, M. Schuchmann, V. Luria, N. Chiannilkulchai, J.S. Beckmann, I.L. Mett, D. Rebrikov, V.M. Brodianski, O.C. Kemper, and O. Kollet Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally Immunity 9 1998 267 276
70. M. Pellegrini, S. Bath, V.S. Marsden, D.C. Huang, D. Metcalf, A.W. Harris, and A. Strasser FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells Blood 106 2005 1581 1589
71. N. Zhang, and Y.W. He An essential role for c-FLIP in the efficient development of mature T lymphocytes J Exp Med 202 2005 395 404
72. H. Chau, V. Wong, N.J. Chen, H.L. Huang, W.J. Lin, C. Mirtsos, A.R. Elford, M. Bonnard, and A. Wakeham Cellular FLICE-inhibitory protein is required for T cell survival and cycling J Exp Med 202 2005 405 413